ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Drugs for Schistosomiasis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-37F412
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Drugs for Schistosomiasis Market Insights and Forecast to 2028
BUY CHAPTERS

Drugs for Schistosomiasis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-37F412
Report
August 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Drugs for Schistosomiasis- Market Size

The global market for Drugs for Schistosomiasis was estimated to be worth US$ 88.3 million in 2024 and is forecast to a readjusted size of US$ 114 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.

Drugs for Schistosomiasis- Market

Drugs for Schistosomiasis- Market

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drugs for Schistosomiasis by region & country, by Type, and by Application.
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
Market Segmentation

Scope of Drugs for Schistosomiasis- Market Report

Report Metric Details
Report Name Drugs for Schistosomiasis- Market
Forecasted market size in 2031 US$ 114 million
CAGR 3.8%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • S. haematobium
  • S. mansoni
  • S. japonicum
  • S. mekongi
  • S. intercalatum
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Drugs for Schistosomiasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Drugs for Schistosomiasis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Drugs for Schistosomiasis- Market size in 2031?

Ans: The Drugs for Schistosomiasis- Market size in 2031 will be US$ 114 million.

Who are the main players in the Drugs for Schistosomiasis- Market report?

Ans: The main players in the Drugs for Schistosomiasis- Market are Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals

What are the Application segmentation covered in the Drugs for Schistosomiasis- Market report?

Ans: The Applications covered in the Drugs for Schistosomiasis- Market report are S. haematobium, S. mansoni, S. japonicum, S. mekongi, S. intercalatum

What are the Type segmentation covered in the Drugs for Schistosomiasis- Market report?

Ans: The Types covered in the Drugs for Schistosomiasis- Market report are Praziquantel, Oxamniquine, Other

Recommended Reports

Antiparasitic Drugs

Gastrointestinal Treatments

Rare and Infectious Diseases

1 Market Overview
1.1 Drugs for Schistosomiasis Product Introduction
1.2 Global Drugs for Schistosomiasis Market Size Forecast
1.2.1 Global Drugs for Schistosomiasis Sales Value (2020-2031)
1.2.2 Global Drugs for Schistosomiasis Sales Volume (2020-2031)
1.2.3 Global Drugs for Schistosomiasis Sales Price (2020-2031)
1.3 Drugs for Schistosomiasis Market Trends & Drivers
1.3.1 Drugs for Schistosomiasis Industry Trends
1.3.2 Drugs for Schistosomiasis Market Drivers & Opportunity
1.3.3 Drugs for Schistosomiasis Market Challenges
1.3.4 Drugs for Schistosomiasis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drugs for Schistosomiasis Players Revenue Ranking (2024)
2.2 Global Drugs for Schistosomiasis Revenue by Company (2020-2025)
2.3 Global Drugs for Schistosomiasis Players Sales Volume Ranking (2024)
2.4 Global Drugs for Schistosomiasis Sales Volume by Company Players (2020-2025)
2.5 Global Drugs for Schistosomiasis Average Price by Company (2020-2025)
2.6 Key Manufacturers Drugs for Schistosomiasis Manufacturing Base and Headquarters
2.7 Key Manufacturers Drugs for Schistosomiasis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drugs for Schistosomiasis
2.9 Drugs for Schistosomiasis Market Competitive Analysis
2.9.1 Drugs for Schistosomiasis Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Drugs for Schistosomiasis Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Praziquantel
3.1.2 Oxamniquine
3.1.3 Other
3.2 Global Drugs for Schistosomiasis Sales Value by Type
3.2.1 Global Drugs for Schistosomiasis Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Drugs for Schistosomiasis Sales Value, by Type (2020-2031)
3.2.3 Global Drugs for Schistosomiasis Sales Value, by Type (%) (2020-2031)
3.3 Global Drugs for Schistosomiasis Sales Volume by Type
3.3.1 Global Drugs for Schistosomiasis Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Drugs for Schistosomiasis Sales Volume, by Type (2020-2031)
3.3.3 Global Drugs for Schistosomiasis Sales Volume, by Type (%) (2020-2031)
3.4 Global Drugs for Schistosomiasis Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 S. haematobium
4.1.2 S. mansoni
4.1.3 S. japonicum
4.1.4 S. mekongi
4.1.5 S. intercalatum
4.2 Global Drugs for Schistosomiasis Sales Value by Application
4.2.1 Global Drugs for Schistosomiasis Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Drugs for Schistosomiasis Sales Value, by Application (2020-2031)
4.2.3 Global Drugs for Schistosomiasis Sales Value, by Application (%) (2020-2031)
4.3 Global Drugs for Schistosomiasis Sales Volume by Application
4.3.1 Global Drugs for Schistosomiasis Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Drugs for Schistosomiasis Sales Volume, by Application (2020-2031)
4.3.3 Global Drugs for Schistosomiasis Sales Volume, by Application (%) (2020-2031)
4.4 Global Drugs for Schistosomiasis Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Drugs for Schistosomiasis Sales Value by Region
5.1.1 Global Drugs for Schistosomiasis Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Drugs for Schistosomiasis Sales Value by Region (2020-2025)
5.1.3 Global Drugs for Schistosomiasis Sales Value by Region (2026-2031)
5.1.4 Global Drugs for Schistosomiasis Sales Value by Region (%), (2020-2031)
5.2 Global Drugs for Schistosomiasis Sales Volume by Region
5.2.1 Global Drugs for Schistosomiasis Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Drugs for Schistosomiasis Sales Volume by Region (2020-2025)
5.2.3 Global Drugs for Schistosomiasis Sales Volume by Region (2026-2031)
5.2.4 Global Drugs for Schistosomiasis Sales Volume by Region (%), (2020-2031)
5.3 Global Drugs for Schistosomiasis Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Drugs for Schistosomiasis Sales Value, 2020-2031
5.4.2 North America Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Drugs for Schistosomiasis Sales Value, 2020-2031
5.5.2 Europe Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Drugs for Schistosomiasis Sales Value, 2020-2031
5.6.2 Asia Pacific Drugs for Schistosomiasis Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Drugs for Schistosomiasis Sales Value, 2020-2031
5.7.2 South America Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drugs for Schistosomiasis Sales Value, 2020-2031
5.8.2 Middle East & Africa Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drugs for Schistosomiasis Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Drugs for Schistosomiasis Sales Value
6.2.1 Key Countries/Regions Drugs for Schistosomiasis Sales Value, 2020-2031
6.2.2 Key Countries/Regions Drugs for Schistosomiasis Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Drugs for Schistosomiasis Sales Value, 2020-2031
6.3.2 United States Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Drugs for Schistosomiasis Sales Value, 2020-2031
6.4.2 Europe Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Drugs for Schistosomiasis Sales Value, 2020-2031
6.5.2 China Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.5.3 China Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Drugs for Schistosomiasis Sales Value, 2020-2031
6.6.2 Japan Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Drugs for Schistosomiasis Sales Value, 2020-2031
6.7.2 South Korea Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Drugs for Schistosomiasis Sales Value, 2020-2031
6.8.2 Southeast Asia Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Drugs for Schistosomiasis Sales Value, 2020-2031
6.9.2 India Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
6.9.3 India Drugs for Schistosomiasis Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Shin Poong
7.1.1 Shin Poong Company Information
7.1.2 Shin Poong Introduction and Business Overview
7.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Shin Poong Drugs for Schistosomiasis Product Offerings
7.1.5 Shin Poong Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck Drugs for Schistosomiasis Product Offerings
7.2.5 Merck Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Introduction and Business Overview
7.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer Drugs for Schistosomiasis Product Offerings
7.3.5 Bayer Recent Development
7.4 EIPICO
7.4.1 EIPICO Company Information
7.4.2 EIPICO Introduction and Business Overview
7.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 EIPICO Drugs for Schistosomiasis Product Offerings
7.4.5 EIPICO Recent Development
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Company Information
7.5.2 Chandra Bhagat Pharma Introduction and Business Overview
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings
7.5.5 Chandra Bhagat Pharma Recent Development
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Company Information
7.6.2 Taj Pharmaceuticals Introduction and Business Overview
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings
7.6.5 Taj Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Drugs for Schistosomiasis Industrial Chain
8.2 Drugs for Schistosomiasis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drugs for Schistosomiasis Sales Model
8.5.2 Sales Channel
8.5.3 Drugs for Schistosomiasis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
List of Tables
 Table 1. Drugs for Schistosomiasis Market Trends
 Table 2. Drugs for Schistosomiasis Market Drivers & Opportunity
 Table 3. Drugs for Schistosomiasis Market Challenges
 Table 4. Drugs for Schistosomiasis Market Restraints
 Table 5. Global Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
 Table 7. Global Drugs for Schistosomiasis Sales Volume by Company (2020-2025) & (M Units)
 Table 8. Global Drugs for Schistosomiasis Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Drugs for Schistosomiasis Price by Company (2020-2025) & (USD/K Units)
 Table 10. Key Manufacturers Drugs for Schistosomiasis Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Drugs for Schistosomiasis Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Drugs for Schistosomiasis
 Table 13. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drugs for Schistosomiasis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Drugs for Schistosomiasis Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Drugs for Schistosomiasis Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Drugs for Schistosomiasis Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Drugs for Schistosomiasis Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Drugs for Schistosomiasis Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)
 Table 22. Global Drugs for Schistosomiasis Sales Volume by Type (2020-2025) & (M Units)
 Table 23. Global Drugs for Schistosomiasis Sales Volume by Type (2026-2031) & (M Units)
 Table 24. Global Drugs for Schistosomiasis Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Drugs for Schistosomiasis Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Drugs for Schistosomiasis Price by Type (2020-2025) & (USD/K Units)
 Table 27. Global Drugs for Schistosomiasis Price by Type (2026-2031) & (USD/K Units)
 Table 28. Global Drugs for Schistosomiasis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Drugs for Schistosomiasis Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Drugs for Schistosomiasis Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Drugs for Schistosomiasis Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Drugs for Schistosomiasis Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Drugs for Schistosomiasis Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)
 Table 34. Global Drugs for Schistosomiasis Sales Volume by Application (2020-2025) & (M Units)
 Table 35. Global Drugs for Schistosomiasis Sales Volume by Application (2026-2031) & (M Units)
 Table 36. Global Drugs for Schistosomiasis Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Drugs for Schistosomiasis Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Drugs for Schistosomiasis Price by Application (2020-2025) & (USD/K Units)
 Table 39. Global Drugs for Schistosomiasis Price by Application (2026-2031) & (USD/K Units)
 Table 40. Global Drugs for Schistosomiasis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Drugs for Schistosomiasis Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Drugs for Schistosomiasis Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Drugs for Schistosomiasis Sales Value by Region (2020-2025) & (%)
 Table 44. Global Drugs for Schistosomiasis Sales Value by Region (2026-2031) & (%)
 Table 45. Global Drugs for Schistosomiasis Sales Volume by Region (M Units): 2020 VS 2024 VS 2031
 Table 46. Global Drugs for Schistosomiasis Sales Volume by Region (2020-2025) & (M Units)
 Table 47. Global Drugs for Schistosomiasis Sales Volume by Region (2026-2031) & (M Units)
 Table 48. Global Drugs for Schistosomiasis Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Drugs for Schistosomiasis Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Drugs for Schistosomiasis Average Price by Region (2020-2025) & (USD/K Units)
 Table 51. Global Drugs for Schistosomiasis Average Price by Region (2026-2031) & (USD/K Units)
 Table 52. Key Countries/Regions Drugs for Schistosomiasis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Drugs for Schistosomiasis Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Drugs for Schistosomiasis Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Drugs for Schistosomiasis Sales Volume, (2020-2025) & (M Units)
 Table 56. Key Countries/Regions Drugs for Schistosomiasis Sales Volume, (2026-2031) & (M Units)
 Table 57. Shin Poong Company Information
 Table 58. Shin Poong Introduction and Business Overview
 Table 59. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 60. Shin Poong Drugs for Schistosomiasis Product Offerings
 Table 61. Shin Poong Recent Development
 Table 62. Merck Company Information
 Table 63. Merck Introduction and Business Overview
 Table 64. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 65. Merck Drugs for Schistosomiasis Product Offerings
 Table 66. Merck Recent Development
 Table 67. Bayer Company Information
 Table 68. Bayer Introduction and Business Overview
 Table 69. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 70. Bayer Drugs for Schistosomiasis Product Offerings
 Table 71. Bayer Recent Development
 Table 72. EIPICO Company Information
 Table 73. EIPICO Introduction and Business Overview
 Table 74. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 75. EIPICO Drugs for Schistosomiasis Product Offerings
 Table 76. EIPICO Recent Development
 Table 77. Chandra Bhagat Pharma Company Information
 Table 78. Chandra Bhagat Pharma Introduction and Business Overview
 Table 79. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 80. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings
 Table 81. Chandra Bhagat Pharma Recent Development
 Table 82. Taj Pharmaceuticals Company Information
 Table 83. Taj Pharmaceuticals Introduction and Business Overview
 Table 84. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 85. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings
 Table 86. Taj Pharmaceuticals Recent Development
 Table 87. Key Raw Materials Lists
 Table 88. Raw Materials Key Suppliers Lists
 Table 89. Drugs for Schistosomiasis Downstream Customers
 Table 90. Drugs for Schistosomiasis Distributors List
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources


List of Figures
 Figure 1. Drugs for Schistosomiasis Product Picture
 Figure 2. Global Drugs for Schistosomiasis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Drugs for Schistosomiasis Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Drugs for Schistosomiasis Sales Volume (2020-2031) & (M Units)
 Figure 5. Global Drugs for Schistosomiasis Sales Price (2020-2031) & (USD/K Units)
 Figure 6. Drugs for Schistosomiasis Report Years Considered
 Figure 7. Global Drugs for Schistosomiasis Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Drugs for Schistosomiasis Players Sales Volume Ranking (2024) & (M Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for Schistosomiasis Revenue in 2024
 Figure 10. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Praziquantel Picture
 Figure 12. Oxamniquine Picture
 Figure 13. Other Picture
 Figure 14. Global Drugs for Schistosomiasis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Drugs for Schistosomiasis Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Drugs for Schistosomiasis Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)
 Figure 17. Global Drugs for Schistosomiasis Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Drugs for Schistosomiasis Price by Type (2020-2031) & (USD/K Units)
 Figure 19. Product Picture of S. haematobium
 Figure 20. Product Picture of S. mansoni
 Figure 21. Product Picture of S. japonicum
 Figure 22. Product Picture of S. mekongi
 Figure 23. Product Picture of S. intercalatum
 Figure 24. Global Drugs for Schistosomiasis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 25. Global Drugs for Schistosomiasis Sales Value Market Share by Application, 2024 & 2031
 Figure 26. Global Drugs for Schistosomiasis Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)
 Figure 27. Global Drugs for Schistosomiasis Sales Volume Market Share by Application, 2024 & 2031
 Figure 28. Global Drugs for Schistosomiasis Price by Application (2020-2031) & (USD/K Units)
 Figure 29. North America Drugs for Schistosomiasis Sales Value (2020-2031) & (US$ Million)
 Figure 30. North America Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
 Figure 31. Europe Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Europe Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
 Figure 33. Asia Pacific Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Drugs for Schistosomiasis Sales Value by Region (%), 2024 VS 2031
 Figure 35. South America Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 36. South America Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
 Figure 37. Middle East & Africa Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 38. Middle East & Africa Drugs for Schistosomiasis Sales Value by Country (%), 2024 VS 2031
 Figure 39. Key Countries/Regions Drugs for Schistosomiasis Sales Value (%), (2020-2031)
 Figure 40. Key Countries/Regions Drugs for Schistosomiasis Sales Volume (%), (2020-2031)
 Figure 41. United States Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 42. United States Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 43. United States Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 44. Europe Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Europe Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 46. Europe Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 47. China Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 48. China Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 49. China Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 50. Japan Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 51. Japan Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 52. Japan Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 53. South Korea Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 54. South Korea Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 55. South Korea Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 56. Southeast Asia Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 57. Southeast Asia Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 58. Southeast Asia Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 59. India Drugs for Schistosomiasis Sales Value, (2020-2031) & (US$ Million)
 Figure 60. India Drugs for Schistosomiasis Sales Value by Type (%), 2024 VS 2031
 Figure 61. India Drugs for Schistosomiasis Sales Value by Application (%), 2024 VS 2031
 Figure 62. Drugs for Schistosomiasis Industrial Chain
 Figure 63. Drugs for Schistosomiasis Manufacturing Cost Structure
 Figure 64. Channels of Distribution (Direct Sales, and Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Anti helminthic Drugs Market Research Report 2024
Global Heartworm Disease Treatment Market Research Report 2025
Global Amebiasis Treatment Market Insights Forecast to 2030
Global Coccidiosis Treatment Market Research Report 2024
Global Liver Fluke Treatment Market Insights Forecast to 2030
Global Amebiasis Therapeutics Market Insights Forecast to 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Albendazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Gastroenteritis Drugs Market Research Report 2024
Heartworm Treatment Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Triclabendazole Market Research Report 2024
Global Amebiasis Drugs Market Insights Forecast to 2030
Global Amebiasis Market Insights Forecast to 2030
Intestinal Ascariasis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection UTI Market Research Report 2024
Global Animal Internal Parasiticide Market Insights Forecast to 2030
Global Bacterial Enteric Disease Testing Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Canine Leptospirosis Treatment Market Research Report 2025
Global Typhoid Fever Diagnostic Fluid Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions